Fifth Third Bancorp’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Buy
4,558
+4,346
+2,050% +$207K ﹤0.01% 2414
2025
Q4
$7.92K Buy
212
+8
+4% +$325 ﹤0.01% 2207
2025
Q3
$8.25K Buy
204
+120
+143% +$3.96K ﹤0.01% 2204
2025
Q2
$2.15K Buy
84
+74
+740% +$1.61K ﹤0.01% 2339
2025
Q1
$214 Buy
+10
New +$223 ﹤0.01% 2499
2023
Q4
Sell
-76
Closed -$971 2618
2023
Q3
$971 Hold
76
﹤0.01% 2460
2023
Q2
$1.04K Sell
76
-10
-12% -$143 ﹤0.01% 2505
2023
Q1
$1.32K Buy
86
+10
+13% +$153 ﹤0.01% 2605
2022
Q4
$1.02K Sell
76
-98
-56% -$1.31K ﹤0.01% 2534
2022
Q3
$2K Buy
+174
New +$3K ﹤0.01% 2456
2022
Q2
Sell
-42
Closed -$1K 2755
2022
Q1
$1K Hold
42
﹤0.01% 2620
2021
Q4
$1K Buy
+42
New +$897 ﹤0.01% 2628
2016
Q1
Sell
-50
Closed -$2K 2585
2015
Q4
$2K Buy
+50
New +$1.6K ﹤0.01% 2486

Other funds holding PAHC

Fifth Third Bancorp's PAHC Position: Q1 2026 in Review

Fifth Third Bancorp increased its Phibro Animal Health (PAHC) stake by 2,050% in Q1 2026, buying an estimated $207K and bringing the position to 4,558 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2414.

Fifth Third Bancorp first reported a position in PAHC in Q4 2015 and has held it in 13 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Fifth Third Bancorp held 4,558 shares of Phibro Animal Health worth $252K as of Q1 2026.
  • Fifth Third Bancorp bought 4,346 Phibro Animal Health shares in Q1 2026, an estimated $207K.
  • Phibro Animal Health made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2414 holding.
  • Fifth Third Bancorp first reported a position in Phibro Animal Health in Q4 2015 and has held it in 13 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.